Neuropeptide signaling and hydrocephalus: SCO with the flow

18Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Congenital hydrocephalus affects 0.1-0.3% of live births, with a high mortality rate (∼50%) in the absence of surgical intervention. Although the insertion of shunts alleviates the symptoms of the majority of congenital cases, the molecular basis of hydrocephalus and the mechanisms of cerebrospinal fluid (CSF) circulation remain largely unknown. Two important players are the subcommissural organ/Reissner's fiber (SCO/RF) complex and the ventricular ependymal (vel) cells that together facilitate the flow of the CSF through the narrow canals of the ventricular system. In this issue of the JCI, Lang et al. demonstrate that overexpression of the pituitary adenylate cyclase-activating polypeptide (PACAP) type I (PAC1) receptor gene results in abnormal development of the SCO and vel cells, leading to congenital hydrocephalus (see the related article beginning on page 1924). The ligand for the PAC1 receptor is the neuropeptide PACAP, which uncovers what the authors believe to be a novel role for this signaling cascade in the regulation of CSF circulation.

Cite

CITATION STYLE

APA

Picketts, D. J. (2006, July 3). Neuropeptide signaling and hydrocephalus: SCO with the flow. Journal of Clinical Investigation. https://doi.org/10.1172/JCI29148

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free